Michiel van der Vlist

Utrecht University — Netherlands

Immunology and Microbiology · Life Sciences

14h-index2.7kcitations37works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(17), Immunotherapy and Immune Responses(13), Immune Response and Inflammation(7), Cancer Immunotherapy and Biomarkers(5), Neuroinflammation and Neurodegeneration Mechanisms(5)

Publications37 total

Targeting Inhibitory Immune Receptors in Inflammatory Disease, Guided by Molecular Understanding of Their Function
Annual Review of Immunology·2026
The scavenger receptor MARCO is a ligand for the immune inhibitory receptor LAIR-1 and regulates its function in cis
Science Signaling·2025
Inhibitory pattern recognition receptors: lessons from LAIR1
Nature reviews. Immunology·2025· 5 cited
Author response: A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2024Open Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
eLife·2024· 9 citedOpen Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2024Open Access
Author response: A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2024Open Access
In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients
Cancer Immunology Immunotherapy·2024· 1 citedOpen Access
Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus
Journal of Translational Autoimmunity·2024· 7 citedOpen Access
m6A Reader YTHDC1 Impairs Respiratory Syncytial Virus Infection by Downregulating Membrane CX3CR1 Expression
Viruses·2024· 8 citedOpen Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2024Open Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
eLife·2024· 4 citedOpen Access
Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection
The Journal of Infectious Diseases·2023· 5 citedOpen Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2023Open Access
Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain
Neuron·2021· 225 citedOpen Access
Signaling by the inhibitory receptor CD200R is rewired by type I interferon
Science Signaling·2021· 11 cited
CD200R1L is a functional evolutionary conserved activating receptor in human neutrophils
Journal of Leukocyte Biology·2021· 8 citedOpen Access
Identification of a novel conserved signaling motif in CD200 receptor required for its inhibitory function
PLoS ONE·2021· 8 citedOpen Access
Identification of a novel conserved signaling motif in CD200 Receptor required for its inhibitory function
2020Open Access
Signal Inhibitory Receptor on Leukocytes-1 is highly expressed on lung monocytes, but absent on mononuclear phagocytes in skin and colon
Cellular Immunology·2020· 9 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Linde Meyaard(21), M Inês Pascoal Ramos(12), Teunis B. H. Geijtenbeek(10), Can Keşmir(10), Jürgen Kuball(8), Akashdip Singh(8), Helen J. von Richthofen(8), Alberto Miranda Bedate(7), Saskia V Vijver(7), Raphael Kuhn(7), Alexander Yermanos(7), Sonja I. Gringhuis(6), Manja Litjens(5), Laura M. Timmerman(5), William Khoury-Hanold(4), Brigitte A. Wevers(3), Jeroen den Dunnen(3), Timothy R. D. J. Radstake(3), Geertje H. A. Westerlaken(3), Lucas L. van den Hoogen(3)